Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, University Of North Carolina
1995
Bachelor of Science in Pharmacy, Auburn University
1989
Fingerprint
Dive into the research topics where Charles Loftin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
Projects & Grants
- 20 Finished
-
Fellowship for Julie Oestreich: The Effects of P2Y12 Polymorphisms on Platelet Receptor Expression and Activation
Loftin, C. & Oestreich, J.
7/1/08 → 3/31/09
Project: Research project
-
Prostanoid-dependent Abdominal Aortic Aneurysm Formation
National Heart Lung and Blood Institute
5/1/07 → 4/30/13
Project: Research project
-
Prostanoid-dependent Abdominal Aortic Aneurysm Formation
National Heart Lung and Blood Institute
5/1/07 → 5/1/07
Project: Research project
-
Julie Oestreich Fellowship: The Effects of P2Y12 Polymorphism on Platelet Receptor Density and Activation
Loftin, C., Oestreich, J. & Wedlund, P.
American Heart Association Ohio Valley Affiliate
7/1/06 → 6/30/08
Project: Research project
-
Center for the Biologic Basis of Oral/Systemic Diseases: Loftin Project 2
National Center for Research Resources
9/23/04 → 7/31/06
Project: Research project
-
A highly selective mPGES-1 inhibitor to block abdominal aortic aneurysm progression in the angiotensin mouse model
Weaver, L. M., Stewart, M. J., Ding, K., Loftin, C. D., Zheng, F. & Zhan, C. G., Dec 2024, In: Scientific Reports. 14, 1, 6959.Research output: Contribution to journal › Article › peer-review
Open Access -
Analgesic effects of a highly selective mPGES-1 inhibitor
Stewart, M. J., Weaver, L. M., Ding, K., Kyomuhangi, A., Loftin, C. D., Zheng, F. & Zhan, C. G., Dec 2023, In: Scientific Reports. 13, 1, 3326.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Development of pharmacotherapies for abdominal aortic aneurysms
Weaver, L. M., Loftin, C. D. & Zhan, C. G., Sep 2022, In: Biomedicine and Pharmacotherapy. 153, 113340.Research output: Contribution to journal › Review article › peer-review
Open Access10 Scopus citations -
DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1
Zhou, S., Zhou, Z., Ding, K., Yuan, Y., Loftin, C., Zheng, F. & Zhan, C. G., Dec 1 2020, In: Scientific Reports. 10, 1, 10187.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs
Ding, K., Zhou, Z., Hou, S., Yuan, Y., Zhou, S., Zheng, X., Chen, J., Loftin, C., Zheng, F. & Zhan, C. G., Dec 1 2018, In: Scientific Reports. 8, 1, 5205.Research output: Contribution to journal › Article › peer-review
Open Access36 Scopus citations